Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620126 · ClinicalTrials.gov registry record · Phase 3
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
A Phase 3 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 3
- Development phase
- 47
- Enrollment target
NCT00620126: Completed Phase 3 study, sponsored by University of Maryland, Baltimore.
NCT00620126 is a Phase 3 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 47 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00620126, a Phase 3 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if home automated telemanagement improves bowel symptoms, quality of life, compliance with medications, and health care utilization compared to best available care in patients with ulcerative colitis.
Primary Outcome
Clinical disease activity was assessed using the Seo index. An activity index \<120 represents clinical remission, whereas scores of 121-150, 151-220, and \>221 correlate with mild, moderate, and severe disease respectively. The Seo index is sensitive to change, with a decrease in the index of 35 correlating with a clinical response.
Interventions
- OTHER UC Home Automated Telemanagement
- OTHER Best Available Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
What the finished NCT00620126 record still lists
NCT00620126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which UC Home Automated Telemanagement is the first listed.
NCT00620126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00620126 about?
NCT00620126 is a clinical study titled "The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis". The purpose of this study is to determine if home automated telemanagement improves bowel symptoms, quality of life, compliance with medications, and health care utilization compared to best available care in patients with ulcerative colitis.
What is the current status of trial NCT00620126?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 47 participants. The study started on 2008-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00620126?
The interventions under investigation include: UC Home Automated Telemanagement (OTHER), Best Available Care (OTHER).
Who is sponsoring clinical trial NCT00620126?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00620126's enrollment target sits among peer trials
47 1867th of 2000 higher than 133 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia